1. Home
  2. IAC vs EWTX Comparison

IAC vs EWTX Comparison

Compare IAC & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IAC Inc.

IAC

IAC Inc.

HOLD

Current Price

$39.50

Market Cap

2.7B

Sector

Technology

ML Signal

HOLD

Logo Edgewise Therapeutics Inc.

EWTX

Edgewise Therapeutics Inc.

HOLD

Current Price

$28.43

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IAC
EWTX
Founded
N/A
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.5B
IPO Year
1992
2021

Fundamental Metrics

Financial Performance
Metric
IAC
EWTX
Price
$39.50
$28.43
Analyst Decision
Buy
Buy
Analyst Count
12
8
Target Price
$45.91
$34.13
AVG Volume (30 Days)
759.3K
1.4M
Earning Date
02-03-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,653,760,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
23.49
N/A
52 Week Low
$29.56
$10.60
52 Week High
$50.49
$30.48

Technical Indicators

Market Signals
Indicator
IAC
EWTX
Relative Strength Index (RSI) 54.03 60.71
Support Level $38.39 $25.92
Resistance Level $40.52 $28.29
Average True Range (ATR) 1.02 1.59
MACD -0.16 0.38
Stochastic Oscillator 53.66 78.71

Price Performance

Historical Comparison
IAC
EWTX

About IAC IAC Inc.

IAC Inc is comprised of businesses including Angi Inc, Dotdash Meredith and Care.com, among many others ranging from early stage to established businesses. Its Dotdash Meredith segment consists of its Digital and Print businesses. Angi segment offers repairing and remodeling homes to cleaning and landscaping services. Care.com segment is a online destination for families to connect with caregivers for their children, aging parents, pets and homes and for caregivers to connect with families seeking care services. Search segment consists of a collection of websites providing general search services and information, and a Desktop business, which includes business-to-business partnership operations.

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.

Share on Social Networks: